2019
DOI: 10.3389/fnint.2019.00045
|View full text |Cite
|
Sign up to set email alerts
|

Conceptual, Regulatory and Strategic Imperatives in the Early Days of EEG-Based Biomarker Validation for Neurodevelopmental Disabilities

Abstract: Biological treatment development for syndromal neuropsychiatric conditions such as autism has seen slow progress for decades. Speeding drug discovery may result from the judicious development and application of biomarker measures of brain function to select patients for clinical trials, to confirm target engagement and to optimize drug dose. For neurodevelopmental disorders, electrophysiology (EEG) offers considerable promise because of its ability to monitor brain activity with high temporal resolution and it… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
58
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
3
2

Relationship

1
9

Authors

Journals

citations
Cited by 59 publications
(58 citation statements)
references
References 71 publications
0
58
0
Order By: Relevance
“…Validating causal models is central to the mechanistic understanding that is fundamental to the scientific enterprise but is also practically important in predicting how putative treatments are likely to be effective or ineffective. Causal understanding is also critical for designing biomarkers that validly report on what they are understood to reflect (Ewen, Sweeney, & Potter, ).…”
Section: Discussionmentioning
confidence: 99%
“…Validating causal models is central to the mechanistic understanding that is fundamental to the scientific enterprise but is also practically important in predicting how putative treatments are likely to be effective or ineffective. Causal understanding is also critical for designing biomarkers that validly report on what they are understood to reflect (Ewen, Sweeney, & Potter, ).…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies showed measurement of markers to understand the complex systems [118][119][120]. The markers include neurotransmitters, hormones and markers of immune function and inflammation [121][122][123][124][125][126][127]. It has been suggested that OS may play a role in etiopathogenesis of ADS, that neurological changes may be due to OS occurring in early brain tissue development and reduced antioxidative barrier [128].…”
Section: Lpas In Subjects With Autismmentioning
confidence: 99%
“…A significant concern to interpretation of SNR measures in ASD is that these methods are sensitive to non-physiological noise, and individuals with ASD may have an increased magnitude of this artifact, including muscle and eye-blink artifact in MEG/EEG [110,111].…”
Section: Signal-to-noisementioning
confidence: 99%